Pfizer announced on May 25 that it will provide all current and future patent-protected medicines and vaccines to 1.2 billion people in 45 low-income countries for non-profit.
Pharmaceutical and biotechnology companies press release This plan is part of an “Agreement for a Healthier World” initiated with the aim of addressing health inequality between many low-income countries and other parts of the world.
Twenty-three medicines and vaccines, available in low-income countries, will help treat and prevent various infectious diseases such as COVID-19, pneumonia and meningitis. It also helps treat certain cancers such as leukemia, breast cancer, and advanced kidney cancer, and helps manage inflammatory and rare diseases.
These medicines are already available in the United States and Europe, but are sold to poor countries at low manufacturing costs with minimal distribution costs.
As Pfizer launches new drugs and vaccines, these products will also be offered to low-income countries that are part of the Accord.
“As we learned from the global COVID-19 vaccine deployment, supply is only the first step in helping patients,” said Albert Bourla, Pfizer’s Chairman and Chief Executive Officer. “Only when all obstacles have been overcome can we end medical inequality and provide it to all patients.”
According to Pfizer, the consensus countries include 27 low-income countries and 18 low- and middle-income countries that have transitioned from low-income to low- and middle-income categories over the last decade.
Initially, the company worked with healthcare professionals from five countries, Rwanda, Ghana, Malawi, Senegal and Uganda, to invite specialists to support diagnosis, “making sure that all medicines and vaccines are needed. We will identify early insights and opportunities to reach you. ” , Healthcare professional education, training, and addressing issues related to supply chain management and other infrastructure enhancements.
According to Pfizer, work in these five countries will be applied to support the deployment of initiatives in the remaining 40 countries.
Pfizer also plans to work with Accord participants to reduce the time it takes to make new drugs and vaccines available in these countries.
The lack of access to these drugs and vaccines in poor countries kills nearly one million people each year, and at least more than 500,000 people are at increased risk of chronic diseases that have a significant impact on quality of life, pharmaceutical giants said. ..
Pfizer is also using funding from the Bill & Melinda Gates Foundation to research vaccines against Group B Streptococcus (GBS), a major cause of childbirth and neonatal mortality in low-income countries.
They are also in talks to support the development of another maternal vaccine, the respiratory syncytial virus (RSV) vaccine.
“Everyone is innovative no matter where they live,” Bill Gates said, promoting an agreement that could help millions of people in low-income countries lead healthier lives. Should have similar access to life-saving medicines and vaccines. “
“Pfizer sets an example for other companies to follow,” Gates said.
Pfizer’s COVID-19 vaccine will reach approximately $ 37 billion in 2021 sales. However, the company sells vaccines in low-income countries for about $ 6.75 each time, and the European Union and the United States pay about $ 19 each time. , Reuters Report.
Overall, Pfizer’s full-year 2021 revenue was $ 81.3 billion, an increase of 92% from 2020.
However, pharmaceutical companies have been under surveillance for the past few months for injuries and deaths associated with the COVID-19 vaccine built on messenger RNA technology.
Researchers at the Centers for Disease Control and Prevention revealed on May 19 that the boy died after being vaccinated against Pfizer’s COVID-19. There is evidence that he is suffering from heart inflammation. vaccination.
Two unnamed teenage boys were previously determined to have died shortly after receiving the Pfizer vaccine, and an autopsy performed by a coroner showed that heart inflammation was the leading cause of death. rice field.
Pfizer was also accused of requesting a 75-year deadline for public release of documents from vaccine clinical trials.
After a group called Public Health and Medical Professionals for Transparency filed a disclosure law request with the U.S. Food and Drug Administration to obtain documents used to approve shots, the company later documented. I was forced to publish.
In January 2022, a judge in Fort Worth, Texas, said: Ordered The FDA releases 55,000 pages of documentation each month until everything is released. This was expected to take about 8 months.